Delivery Order SPE2DB25D3017-SPE2DB26FVGXA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,340.37 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded order issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,990.49 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price, non-competitive delivery order represents a small-value pharmaceutical procurement executed under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,018.76 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on October 17, 2025, with completion targeted for October 20, 2025. This competitively awarded, non-set-aside order utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $5,694.15 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Mounjaro 15 mg/0.5 ml pens, with an ultimate completion date of October 23, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $5,733.34 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens under a firm fixed-price contract. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pens on July 14, 2025, with completion expected by July 15, 2025. This firm fixed price delivery order represents a non-competitive award and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $46,456.89 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens. This firm fixed-price, competitively awarded delivery order was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's competitive standing...
- The Defense Logistics Agency awarded a delivery order valued at $16,194.28 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,448.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units). The contract is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.68 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen (0.5 ml) with a firm fixed price structure. The award, issued on November 7, 2025, is a non-set-aside competitive procurement with an ultimate completion date of November 10, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB26FVGXADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,354.16 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on November 5, 2025, with completion targeted for November 6, 2025. This firm fixed-price delivery order represents a non-competitive award and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare operations globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of federal contracts predominantly with the DLA Medical Supply Chain. The company consistently demonstrates capability to meet federal procurement requirements through competitive processes, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular order for Mounjaro, a diabetes medication, reflects the company's role as a key supplier of specialty pharmaceutical products to military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 11/5/25 |